Why the study?
Patients with cardiac inherited disease have suboptimal adherence to long-term β-blocker therapy, risking sudden cardiac death, but the clinical and psychosocial variables associated with non-adherence are unclear.
What are the clinical and psychosocial variables associated with β-blocker non-adherence in patients with cardiac inherited disease?
Population
130 individuals taking β-blockers from the New Zealand Cardiac Inherited Disease Registry
Comparison
Adherent vs non-adherent patients
Design
Registry-based cross-sectional questionnaire study
Authors
Loading...
May guide adherence interventions in CID; leaves open impact on sudden death risk.
What are the clinical and psychosocial variables associated with β-blocker non-adherence in patients with cardiac inherited disease?
Younger age, channelopathy diagnosis, and negative medication beliefs are significant predictors of beta-blocker non-adherence in patients with cardiac inherited diseases, highlighting targets for adherence interventions.
O’Donovan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: